Range
3.75 - 3.99
Vol / Avg.
123.4K/84.6K
Div / Yield
-
52 Wk
3.72 - 9.74
Mkt Cap
123.2M
Payout Ratio
-
Open
3.88
P/E
-
EPS
-0.33
Shares
32.2M
Outstanding
32.2M
Total Float
22.7M
load more
Sector: Health Care.Industry: Biotechnology
LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, its proprietary technology platform. Its product candidates include LB-001, LB-101, LB-201 and LB 301.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-08
REV
Q2 2021Est.ActualSurprise
EPS-0.240-0.330 -0.0900
REV6.970M802.000K-6.168M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

LogicBio Therapeutics Questions & Anwsers

Q

How do I buy LogicBio Therapeutics (LOGC) stock?

A

You can purchase shares of LogicBio Therapeutics (NASDAQ: LOGC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are LogicBio Therapeutics's (LOGC) competitors?

Q

What is the target price for LogicBio Therapeutics (LOGC) stock?

A

The latest price target for LogicBio Therapeutics (NASDAQ: LOGC) was reported by HC Wainwright & Co. on June 7, 2021. The analyst firm set a price target for 15.00 expecting LOGC to rise to within 12 months (a possible 292.67% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for LogicBio Therapeutics (LOGC)?

A

The stock price for LogicBio Therapeutics (NASDAQ: LOGC) is $3.82 last updated Mon Oct 25 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does LogicBio Therapeutics (LOGC) pay a dividend?

A

There are no upcoming dividends for LogicBio Therapeutics.

Q

When is LogicBio Therapeutics (NASDAQ:LOGC) reporting earnings?

A

LogicBio Therapeutics’s $Q3 earnings are confirmed for after-market on $November 8, 2021.

Q

Is LogicBio Therapeutics (LOGC) going to split?

A

There is no upcoming split for LogicBio Therapeutics.

Q

What sector and industry does LogicBio Therapeutics (LOGC) operate in?

A

LogicBio Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.